Protein identified as potential druggable target for pancreatic cancer
(University of Texas M. D. Anderson Cancer Center) A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate. PRMT1 is involved in a number of genetic processes including gene transcription, DNA repair and signaling.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastroschisis Repair | Genetics | Pancreas | Pancreatic Cancer | Texas University